Specimen:
Collect
- One SST
Also Acceptable:
- One Green Top (Li Heparin)
- One Lavender (EDTA)
- One Red Top
Submit
- 1 mL (Min:0.5 mL) Serum . Submit Refrigerated. Submit in a Standard Transport Tube.
Also Acceptable:
- 1 mL (Min:0.5 mL) Plasma . Submit Refrigerated. Submit in a Standard Transport Tube.
Special Handling
- Allow specimen to clot completely at room temperature
- Avoid Repeated Freeze/Thaw Cycles
- Separate from cells ASAP
- For patients receiving therapy with high biotin doses (>5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.
Rejection Criteria
- Grossly Hemolyzed Samples
Stability
Ambient: 8 Day(s); Refrigerated: 2 Week(s); Frozen: 12 Month(s); Incubated: Unacceptable
Methodology
- Electrochemiluminescent Immunoassay
Performed
Sun-Sat
Reported
1-2 Day(s)
CPT Codes
- 83874
Interpretive Data
General Reference Range : 25-72 ng/ml
Male Reference Ranges
Female Reference Ranges
Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with this test and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.
Male Reference Ranges
- 0 - 150 year(s) : 28-72 ng/ml
Female Reference Ranges
- 0 - 150 year(s) : 25-58 ng/ml
Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with this test and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.
Components
- 2272 - MYOGLOBIN
Last Updated: March 15, 2025 @ 9:13 am
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date. Updated test information can only be guaranteed by using this website.
